FTC Taking Mulligans With The Tech Sector

FTC Taking Mulligans With The Tech Sector

30 Oct 2019

You’ll never see Tiger Woods ask for a do-over, also known in golfing circles as a “mulligan.” The rules of golf prohibit mulligans.  In the eyes of  the U.S. Federal Trade Commission, however, the rules of antitrust do not.  According to Bruce Hoffman, Director of the FTC’s Bureau of Competition, it may take some mulligans as the Bureau revisits previously approved mergers, particularly in the technology sector.  In testimony before the U.S. Senate Subcommittee on Antitrust, Competition Policy and Consumer Rights, Hoffman announced that the FTC has begun reconsidering certain approved and completed mergers in the digital technology markets.  Upon re-examination, Hoffman says, the FTC may reverse its own prior approval and seek remedies including the unwinding of mergers that it may have gotten wrong the first time around.  For companies subject to such re-review, the prospect of post hoc divestiture is definitely not “par for the course.” 

Share this post on
About Faruqi & Faruqi, LLP

Faruqi & Faruqi, LLP focuses on complex civil litigation, including securities, antitrust, wage and hour and consumer class actions as well as shareholder derivative and merger and transactional litigation. The firm is headquartered in New York, and maintains offices in Atlanta, Los Angeles and Philadelphia.

Since its founding in 1995, Faruqi & Faruqi, LLP has served as lead or co-lead counsel in numerous high-profile cases which ultimately provided significant recoveries to investors, direct purchasers, consumers and employees.

To schedule a free consultation with our attorneys and to learn more about your legal rights, call our offices today at (877) 247-4292 or (212) 983-9330.

About Stephen Doherty

Stephen Doherty is Senior Counsel in the Pennsylvania office of Faruqi & Faruqi, LLP.   Mr. Doherty practices in the area of antitrust law and is significantly involved in prosecuting antitrust class actions on behalf of direct purchasers of brand name and generic drugs and charging pharmaceutical manufacturers with price fixing and with illegally blocking the market entry of less expensive competitors.

Stephen Doherty
Senior Counsel at Faruqi & Faruqi, LLP
Pennsylvania office
Tel:(215) 277-5770
Fax:(215) 277-5771
E-mail:sdoherty@faruqilaw.com
Tags: Antitrust, faruqi & faruqi, FaruqiLaw, FTC

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.
Send Us a Message
New York
685 Third Avenue 26th Floor
New York New York 10017
(877) 247-4292 / (212) 983-9330
(212) 983-9331
Los Angeles
1901 Avenue of the Stars Suite 1060
Los Angeles California 90067
(424) 256-2884
(424) 256-2885
Atlanta
3565 Piedmont Road NE Building Four, Suite 380
Atlanta Georgia 30305
(404) 847-0617
(404) 506-9534
Philadelphia
1617 JFK Boulevard, Suite 1550 Philadelphia
Pennsylvania 19103
(215) 277-5770
(215) 277-5771